CBER Reports
CBER Reports are a summary of regulatory, research, and administrative accomplishments for the last 2 fiscal years and related reports.
Sub-Topic Paragraphs
General

CY 2024 Report from the Director

FDA Report to Congress: Least Burdensome Training Audit

FDA Report to Congress: Least Burdensome Training Audit Addendum

User Fee Billable Biologic Products and Potencies Approved Under Section 351 of…

Biologics PREA Reviews and Labeling Changes
